200 related articles for article (PubMed ID: 23159616)
21. Activation of liver X receptor attenuates endothelin-1 expression in vascular endothelial cells.
Gao M; Zeng Y; Guan Y; Hu Z; Zhong D; Shen X; Zhang L; Xu Z; Gong W; Zhang Y; Zhang M; Zheng Y; He F
Int J Biochem Cell Biol; 2012 Dec; 44(12):2299-307. PubMed ID: 23018104
[TBL] [Abstract][Full Text] [Related]
22. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts.
Luchin A; Purdom G; Murphy K; Clark MY; Angel N; Cassady AI; Hume DA; Ostrowski MC
J Bone Miner Res; 2000 Mar; 15(3):451-60. PubMed ID: 10750559
[TBL] [Abstract][Full Text] [Related]
23. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
Gong W; Dou H; Liu X; Sun L; Hou Y
Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
[TBL] [Abstract][Full Text] [Related]
24. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
25. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.
Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP
In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499
[TBL] [Abstract][Full Text] [Related]
26. Impaired osteoclastogenesis by staphylococcal lipoteichoic acid through Toll-like receptor 2 with partial involvement of MyD88.
Yang J; Ryu YH; Yun CH; Han SH
J Leukoc Biol; 2009 Oct; 86(4):823-31. PubMed ID: 19602669
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
Asai K; Funaba M; Murakami M
Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB.
Kim WS; Kim HJ; Lee ZH; Lee Y; Kim HH
Exp Cell Res; 2013 Feb; 319(4):436-46. PubMed ID: 23246654
[TBL] [Abstract][Full Text] [Related]
29. Saliva suppresses osteoclastogenesis in murine bone marrow cultures.
Caballé-Serrano J; Cvikl B; Bosshardt DD; Buser D; Lussi A; Gruber R
J Dent Res; 2015 Jan; 94(1):192-200. PubMed ID: 25297116
[TBL] [Abstract][Full Text] [Related]
30. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
Kim HS; Suh KS; Sul D; Kim BJ; Lee SK; Jung WW
Int J Mol Med; 2012 Feb; 29(2):169-77. PubMed ID: 22038020
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
Takeshita S; Kaji K; Kudo A
J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol-sensing receptors, liver X receptor alpha and beta, have novel and distinct roles in osteoclast differentiation and activation.
Robertson KM; Norgård M; Windahl SH; Hultenby K; Ohlsson C; Andersson G; Gustafsson JA
J Bone Miner Res; 2006 Aug; 21(8):1276-87. PubMed ID: 16869726
[TBL] [Abstract][Full Text] [Related]
33. Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo.
Kimura K; Kitaura H; Fujii T; Hakami ZW; Takano-Yamamoto T
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):219-27. PubMed ID: 22067001
[TBL] [Abstract][Full Text] [Related]
34. Liver X Receptor activation delays chondrocyte hypertrophy during endochondral bone growth.
Sun MM; Beier F
Osteoarthritis Cartilage; 2014 Jul; 22(7):996-1006. PubMed ID: 24852699
[TBL] [Abstract][Full Text] [Related]
35. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.
Kitami S; Tanaka H; Kawato T; Tanabe N; Katono-Tani T; Zhang F; Suzuki N; Yonehara Y; Maeno M
Biochimie; 2010 Apr; 92(4):398-404. PubMed ID: 20045440
[TBL] [Abstract][Full Text] [Related]
36. Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRα.
Kiss E; Popovic Z; Bedke J; Wang S; Bonrouhi M; Gretz N; Stettner P; Teupser D; Thiery J; Porubsky S; Adams J; Gröne HJ
Am J Pathol; 2011 Jul; 179(1):92-103. PubMed ID: 21703396
[TBL] [Abstract][Full Text] [Related]
37. Neuropeptide FF attenuates RANKL-induced differentiation of macrophage-like cells into osteoclast-like cells.
Sun Y; Chen X; Chen Z; Ma X; Li D; Shang P; Qian A
Arch Oral Biol; 2015 Feb; 60(2):282-92. PubMed ID: 25463906
[TBL] [Abstract][Full Text] [Related]
38. Growth/differentiation factor-15 inhibits differentiation into osteoclasts--a novel factor involved in control of osteoclast differentiation.
Vanhara P; Lincová E; Kozubík A; Jurdic P; Soucek K; Smarda J
Differentiation; 2009 Nov; 78(4):213-22. PubMed ID: 19695766
[TBL] [Abstract][Full Text] [Related]
39. Enterococcus faecalis promotes osteoclastogenesis and semaphorin 4D expression.
Wang S; Deng Z; Seneviratne CJ; Cheung GS; Jin L; Zhao B; Zhang C
Innate Immun; 2015 Oct; 21(7):726-35. PubMed ID: 26138525
[TBL] [Abstract][Full Text] [Related]
40. Arctigenin suppresses receptor activator of nuclear factor κB ligand (RANKL)-mediated osteoclast differentiation in bone marrow-derived macrophages.
Kim AR; Kim HS; Lee JM; Choi JH; Kim SN; Kim DK; Kim JH; Mun SH; Kim JW; Jeon HS; Kim YM; Choi WS
Eur J Pharmacol; 2012 May; 682(1-3):29-36. PubMed ID: 22387094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]